What is Azyp?
Azyp, LLC operates at the intersection of advanced material science and analytical chemistry. The company specializes in the development of high-performance stationary phases, including chiral and HILIC variants, which are essential for complex molecular separation. By leveraging innovative superficially porous particle (SPP) technologies, Azyp provides the research and development sector with tools that significantly enhance laboratory efficiency and precision. Their portfolio, which extends to specialized mass spectrometry reagents, serves as a critical infrastructure component for process chemistry and the commercialization of pharmaceutical and chemical products. Through its commitment to technical excellence, Azyp has established itself as a vital partner for organizations requiring high-fidelity analytical data.
How much funding has Azyp raised?
Azyp has raised a total of $28K across 1 funding round:
Debt
$28K
Debt (2021): $28K with participation from PPP
Key Investors in Azyp
PPP
Public-Private Partnership
What's next for Azyp?
With the infusion of $28K, Azyp is poised to scale its operational capacity and broaden its reach within the global life sciences market. The strategic focus for the coming fiscal periods will likely center on the commercialization of its next-generation SPP technologies and the expansion of its mass spectrometry service offerings. By strengthening its R&D pipeline, the company aims to address the increasing demand for high-throughput analytical solutions in drug discovery and quality control. As Azyp transitions through this growth phase, the focus will remain on maintaining its competitive edge in separation science while optimizing its supply chain to meet the rigorous requirements of its industrial and academic clientele.
See full Azyp company page
